InvestorsHub Logo
Followers 44
Posts 10455
Boards Moderated 0
Alias Born 01/13/2016

Re: tcm55 post# 16253

Tuesday, 10/25/2022 6:51:09 AM

Tuesday, October 25, 2022 6:51:09 AM

Post# of 16706
I. Don’t think that is
A given.. however the phase 1. Trials uskualy are ncot blinded so this is a
Very good sign.
After reading Yale announce it does seem
Algernon has done what they may to protect IP ..
This. Probably savers them a lot of ‘money..

I again direct the company to fill how anavex lead in funding clinical research